Medical device company Boston Scientific (NYSE:BSX) announced better-than-expected revenue in Q3 2026, with revenue rising 1.4% year on year to $5.14 billion. On the other hand, next quarter’s revenue ...
Original Image Link
Source:finance.yahoo.com
Original Image Link
Source:finance.yahoo.com
Posted: 2026-10-28 04:13:00









